Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -21.35%477.18M | -21.21%131.98M | -33.23%110.39M | -26.27%108.49M | -0.31%126.32M | 27.62%606.68M | 32.95%167.51M | 23.82%165.32M | 40.65%147.15M | 13.91%126.71M |
| Cost of revenue | -8.71%528.33M | -10.49%144.92M | -13.39%130.16M | -14.77%117.92M | 5.58%135.33M | 3.13%578.72M | 14.77%161.9M | -0.98%150.28M | 9.09%138.36M | -9.25%128.18M |
| Gross profit | -282.87%-51.15M | -331.07%-12.94M | -231.39%-19.76M | -207.26%-9.43M | -514.67%-9.01M | 132.60%27.97M | 137.15%5.6M | 182.41%15.04M | 139.58%8.79M | 95.11%-1.47M |
| Operating expense | 157.96%18.84M | 110.84%4.69M | 1.57%4.59M | -14.61%4.92M | 806.85%4.63M | -278.77%-32.5M | -425.57%-43.29M | 213.28%4.52M | -3.78%5.76M | -91.78%511K |
| Selling and administrative expenses | 13.17%29.94M | 27.07%10.18M | 1.46%6.34M | 7.96%6.87M | 12.23%6.55M | -12.03%26.45M | -40.73%8.01M | -11.05%6.25M | -11.11%6.36M | -18.15%5.84M |
| -General and administrative expense | 13.17%29.94M | 27.07%10.18M | 1.46%6.34M | 7.96%6.87M | 12.23%6.55M | -12.03%26.45M | -40.73%8.01M | -11.05%6.25M | -11.11%6.36M | -18.15%5.84M |
| Other operating expenses | --506K | --506K | ---- | ---- | ---- | ---- | ---- | ---- | --782K | --249K |
| Total other operating income | -80.31%11.61M | -88.33%5.99M | 1.16%1.75M | 40.85%1.95M | -65.59%1.92M | 182.86%58.95M | 1,013.74%51.3M | -84.30%1.73M | 18.21%1.38M | 506.86%5.58M |
| Operating profit | -215.73%-69.98M | -136.07%-17.64M | -331.53%-24.36M | -573.12%-14.35M | -590.19%-13.65M | 158.16%60.47M | 272.32%48.89M | 173.77%10.52M | 110.76%3.03M | 94.54%-1.98M |
| Net non-operating interest income (expenses) | 8.22%-2.71M | 27.56%-565K | 22.79%-620K | -8.83%-653K | -13.32%-876K | -897.04%-2.96M | 39.95%-780K | 14.39%-803K | 35.14%-600K | 20.80%-773K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | 30.65%5.89M | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -8.22%2.71M | -27.56%565K | -22.79%620K | 8.83%653K | 13.32%876K | -17.72%2.96M | -39.95%780K | -14.39%803K | -35.14%600K | -20.80%773K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | -66.91%180K | ---- | ---- | ---- | ---- |
| Net investment income | 142.49%11.99M | 100.83%264K | -2,057.11%-7.44M | -153.82%-1.63M | 11,517.88%20.8M | -28.23M | -53,116.67%-31.81M | -96.80%380K | -20.07%3.03M | -77.23%179K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 469.64%50.84M | |||||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | -469.64%-50.84M | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -307.27%-60.7M | -210.02%-17.94M | -421.03%-32.41M | -404.58%-16.63M | 344.07%6.28M | 130.93%29.29M | 155.05%16.3M | 403.12%10.1M | 121.55%5.46M | 92.94%-2.57M |
| Income tax | 365.28%2.24M | 1,117.07%998K | 369.19%990K | 32.74%150K | 33.33%100K | 111.00%481K | 138.50%82K | -4.52%211K | 345.65%113K | 101.73%75K |
| Net income | -318.50%-62.94M | -216.73%-18.93M | -437.89%-33.4M | -413.82%-16.78M | 333.37%6.18M | 131.90%28.81M | 155.17%16.22M | 378.32%9.89M | 121.14%5.35M | 91.75%-2.65M |
| Net income continuous operations | -318.50%-62.94M | -216.73%-18.93M | -437.89%-33.4M | -413.82%-16.78M | 333.37%6.18M | 131.90%28.81M | 155.17%16.22M | 378.32%9.89M | 121.14%5.35M | 91.75%-2.65M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -318.50%-62.94M | -216.73%-18.93M | -437.89%-33.4M | -413.82%-16.78M | 333.37%6.18M | 131.90%28.81M | 155.17%16.22M | 378.32%9.89M | 121.14%5.35M | 91.75%-2.65M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -318.50%-62.94M | -216.73%-18.93M | -437.89%-33.4M | -413.82%-16.78M | 333.37%6.18M | 131.90%28.81M | 155.17%16.22M | 378.32%9.89M | 121.14%5.35M | 91.75%-2.65M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -316.91%-0.0295 | -217.11%-0.0089 | -434.04%-0.0157 | -416.00%-0.0079 | 323.08%0.0029 | 131.78%0.0136 | 154.68%0.0076 | 376.47%0.0047 | 120.83%0.0025 | 91.45%-0.0013 |
| Diluted earnings per share | -320.15%-0.0295 | -217.11%-0.0089 | -441.30%-0.0157 | -416.00%-0.0079 | 323.08%0.0029 | 131.31%0.0134 | 154.68%0.0076 | 370.59%0.0046 | 120.83%0.0025 | 91.45%-0.0013 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.